Teduglutide
TAK-633-3009
Phase 3 small_molecule active
Quick answer
Teduglutide for Short Bowel Syndrome is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 13 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Short Bowel Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active